Taiwanese Manufacturer Cited for Multiple Violations

Drug Industry Daily
A A
The FDA flagged UBI Pharma for a slew of violations at its Hsinchu County, Taiwan, facility including inadequate environmental monitoring and sterility practices.

To View This Article:

Login

Subscribe To Drug Industry Daily